Serum GAS6, sAXL, IL-10, NO, and BCL-2 levels are decreased in patients with Behçet’s disease

PURPOSE: Behçet’s disease (BD) is an autoimmune chronic systemic inflammatory disease characterized by a versatile clinical spectrum. Growth arrest specific protein 6 (GAS6)/soluble AXL (sAXL) signaling pathway draws attention in the resolution of inflammation, and its deficiency is associated with...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Indian J Ophthalmol
Päätekijät: Baskol, Gulden, Yetkin, Merve Ö., Sevim, Duygu G, Guclu, Kenan, Arda, Hatice, Saracoglu, Hatice, Gahramanov, Kamran, Evereklioglu, Cem
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Wolters Kluwer -- Medknow Publications 2024
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC467006/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/38648454/
https://ncbi.nlm.nih.govhttps://doi.org/10.4103/IJO.IJO_2829_23
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia